Condition
Impaired Glucose Tolerance (IGT)
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
100%
3 of 3 completed with results
Key Signals
3 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 4 (3)
Trial Status
Completed3
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02969798Not ApplicableRecruiting
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
NCT03398356Phase 4Completed
Metformin and Its Impact on the Substances Associated With NO Production in Prediabetes Patients.
NCT01588418Phase 4CompletedPrimary
Acute Effect of Exenatide on Brain Glucose Metabolism
NCT00787215Unknown
A Survey on the Rate of Glucose Intolerance in Hong Kong Chinese
NCT02287402Phase 4CompletedPrimary
Postmarketing Clinical Study on AO-128
Showing all 5 trials